BATF2 deletion promotes ubiquitylation-mediated p53 degradation, which can activate ERK signaling and promote ERK phosphorylation and the expression of MMP2, MMP9, and cyclin D1, accelerating GC cell proliferation, invasion, and metastasis (18). Here, BATF2 is linked to gastric cancer.